Aisling Capital
Overview
Aisling Capital Believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of human genome has given scientists new insights into the cause of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses.
Investment Focus
- Companies developing and commercializing innovative healthcare products and services
- Addressing unmet medical needs
- Potential for significant growth
Portfolio Companies
Reach Aisling Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Aisling Capital
What sectors does Aisling Capital invest in?
Aisling Capital invests in Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Consumer Health, and is based in New York, New York, United States. Aisling Capital is listed as a vc in the ConnectSafely investor database.
What stage does Aisling Capital invest at?
Aisling Capital backs companies at Seed, Early Stage, Growth, Late Stage and Buyout, writing cheques of 20M - 50M.
Which regions does Aisling Capital invest in?
Aisling Capital invests across United States and Western Europe.
Who are the partners at Aisling Capital?
Team members listed for Aisling Capital include Dennis Purcell (Founder and Senior Advisor) and Eric Aguiar (Partner).
What companies has Aisling Capital invested in?
Aisling Capital's portfolio includes Harmony Biosciences, Biohaven Pharmaceuticals, Loxo Oncology, Aclaris Therapeutics, ZELTIQ Aesthetics and Aimmune Therapeutics.
How do I contact Aisling Capital?
Aisling Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
